Monogram Reconciled Depreciation from 2010 to 2024

MGRM Stock   1.97  0.01  0.51%   
Monogram Orthopaedics Reconciled Depreciation yearly trend continues to be very stable with very little volatility. Reconciled Depreciation is likely to drop to about 273.7 K. During the period from 2010 to 2024, Monogram Orthopaedics Reconciled Depreciation quarterly data regression pattern had sample variance of 21.2 B and median of  31,763. View All Fundamentals
 
Reconciled Depreciation  
First Reported
2010-12-31
Previous Quarter
408 K
Current Value
273.7 K
Quarterly Volatility
145.6 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Monogram Orthopaedics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Monogram Orthopaedics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 433 K, Interest Expense of 18.5 K or Selling General Administrative of 4.3 M, as well as many indicators such as Price To Sales Ratio of 417, Dividend Yield of 0.0 or PTB Ratio of 6.04. Monogram financial statements analysis is a perfect complement when working with Monogram Orthopaedics Valuation or Volatility modules.
  
Check out the analysis of Monogram Orthopaedics Correlation against competitors.

Latest Monogram Orthopaedics' Reconciled Depreciation Growth Pattern

Below is the plot of the Reconciled Depreciation of Monogram Orthopaedics Common over the last few years. It is Monogram Orthopaedics' Reconciled Depreciation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Monogram Orthopaedics' overall financial position and show how it may be relating to other accounts over time.
Reconciled Depreciation10 Years Trend
Slightly volatile
   Reconciled Depreciation   
       Timeline  

Monogram Reconciled Depreciation Regression Statistics

Arithmetic Mean120,244
Geometric Mean64,498
Coefficient Of Variation121.11
Mean Deviation121,248
Median31,763
Standard Deviation145,631
Sample Variance21.2B
Range376.2K
R-Value0.78
Mean Square Error9.1B
R-Squared0.60
Significance0.0007
Slope25,279
Total Sum of Squares296.9B

Monogram Reconciled Depreciation History

2024273.7 K
2023408 K
2022386.7 K
2021322 K
202095.7 K

About Monogram Orthopaedics Financial Statements

Monogram Orthopaedics investors utilize fundamental indicators, such as Reconciled Depreciation, to predict how Monogram Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Reconciled Depreciation408 K273.7 K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Monogram Orthopaedics is a strong investment it is important to analyze Monogram Orthopaedics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Monogram Orthopaedics' future performance. For an informed investment choice regarding Monogram Stock, refer to the following important reports:
Check out the analysis of Monogram Orthopaedics Correlation against competitors.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Monogram Orthopaedics. If investors know Monogram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Monogram Orthopaedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.47)
Revenue Per Share
0.012
Return On Assets
(0.61)
Return On Equity
(1.22)
The market value of Monogram Orthopaedics is measured differently than its book value, which is the value of Monogram that is recorded on the company's balance sheet. Investors also form their own opinion of Monogram Orthopaedics' value that differs from its market value or its book value, called intrinsic value, which is Monogram Orthopaedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Monogram Orthopaedics' market value can be influenced by many factors that don't directly affect Monogram Orthopaedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Monogram Orthopaedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Monogram Orthopaedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Monogram Orthopaedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.